Suggestions
Juan Pablo Cappello
Co-Founder & Managing Partner PAG Law PLLC
Juan Pablo Cappello is the Co-Founder and Managing Partner at PAG Law PLLC.2 He is also the Co-Founder & CEO at Nue Life Health.4 Juan Pablo is a well-known entrepreneur deeply involved in supporting venture capital and impact investing in Latin America.15 Poder Magazine named him one of the “Most Influential Hispanics” in science and technology.145 Business Leader magazine also selected him as a “Top 50 Entrepreneur”.16
Cappello co-founded several companies, including15:
- Idea.me, the first Latin American crowdfunding site15
- The LAB Miami, a 10,000 sq.ft. campus for creative entrepreneurs in Miami’s Wynwood Arts District135
- Mela Artisans, a retail site promoting sustainable livelihoods for artisans in India1
Before PAG Law, Juan Pablo was a Principal Shareholder in the Latin American Group of Greenberg Traurig, an international law firm.56 Earlier, he was a Partner and Director of Patagon.com, which was sold to Banco Santander for over US$750 million.156
Juan Pablo has been involved in crypto and BTC as an investor and legal advisor since 2012.5 US News/Best Lawyers named him "Lawyer of the Year" in 2019 for Derivatives and Futures Law in Miami.5
Cappello earned a bachelor's degree in Economics from Duke University (1985-1989) and a J.D. from NYU School of Law (1989-1992).35 He is admitted to practice in Florida and New York and is fluent in Spanish.5
Highlights
https://lnkd.in/gNMwdCEY
At PAG LAW, we built a law firm for entrepreneurs. Happy to share that two more renowned lawyers joined the firm-Alejandro D. Fiuza and Clara Krivoy.
Alejandro and Clara each bring decades of experience advising business clients. Their sage counsel will elevate our practice and provide our clients with unparalleled access to top-tier legal expertise. They both are extremely well respected throughout Latin America and in the US as top-tier business advisors.
In my recent article "Profit Over Patients? A Critical Look at At-Home Ketamine Therapy", I sought to spark a dialogue on what I perceive to be the over-prescription of ketamine without adequate therapeutic support.
The reception has been diverse, indicative of a conversation that is both necessary and overdue.
Let me directly address the concerns raised by my peers...
